Key facts
- Rubitection’s last known valuation is $10.0M (May 2025).
- It has raised $1.3M; the latest was Equity Crowdfunding ($410K) in May 2025.
- Notable investors include Techstars, US National Science Foundation, MassChallenge, VentureWell, Innovation Works — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Rubitection
- ·The full record, as it builds
Funding rounds
No funding rounds for Rubitection are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rubitection
Developer of an AI-powered care management platform designed to enhance the assessment and treatment of chronic wounds and dermatological conditions. The company's platform provides reliable, data-driven insights for managing diabetic foot ulcers, bed sores, psoriasis and eczema, enabling healthcare providers to improve prevention, reduce costs and enhance patient outcomes.
- Sector
- Healthcare
- HQ
- Pittsburgh, PA, United States
- Founded
- 2010
- Employees
- 8
- Website
- rubitection.com/
- Ownership
- Privately Held (backing)
Rubitection doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rubitection shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rubitection in its N-PORT filings yet. We sweep new filings monthly.